Location: Boston, MA
CIK: 0001346824 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 13, 2015
Total Value: $696M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACHILLION PHARMACEUTICALS INC | 11,733,815 | $81.08M | 11.6% | $6.36 | — | COM | 00448Q201 |
| — | AXOVANT SCIENCES LTD | 5,000,000 | $64.6M | 9.3% | $20.38 | — | COM | G0750W104 |
| — | DYAX CORP | 2,551,193 | $48.7M | 7.0% | $8.24 | — | COM | 26746E103 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 1,553,175 | $34.34M | 4.9% | $17.29 | +4.1% | COM | 19459J104 |
| TGTX | TG THERAPEUTICS INC | 3,124,480 | $31.5M | 4.5% | $10.99 | +35.6% | COM | 88322Q108 |
| — | REGULUS THERAPEUTICS INC | 4,039,823 | $26.42M | 3.8% | $15.20 | — | COM | 75915K101 |
| CHRS | COHERUS BIOSCIENCES INC | 1,305,020 | $26.15M | 3.8% | $14.11 | +115.7% | COM | 19249H103 |
| ASND | ASCENDIS PHARMA A S | 1,461,268 | $25.86M | 3.7% | $17.50 | — | SPONSORED ADR | 04351P101 |
| — | ZOGENIX INC | 1,679,500 | $22.67M | 3.3% | $13.50 | — | COM NEW | 98978L204 |
| — | AQUINOX PHARMACEUTICALS INC | 1,532,151 | $21.56M | 3.1% | $14.07 | — | COM | 03842B101 |
| — | PROTEON THERAPEUTICS INC | 1,506,872 | $20.96M | 3.0% | $11.67 | — | COM | 74371L109 |
| — | AIMMUNE THERAPEUTICS INC | 790,200 | $20.01M | 2.9% | $25.32 | — | COM | 00900T107 |
| — | DICERNA PHARMACEUTICALS INC | 2,428,571 | $19.94M | 2.9% | $28.25 | — | COM | 253031108 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 457,142 | $19.27M | 2.8% | $42.16 | — | COM | 37890U108 |
| — | BLUEPRINT MEDICINES CORP | 878,348 | $18.74M | 2.7% | $26.49 | — | COM | 09627Y109 |
| ARDX | ARDELYX INC | 1,064,013 | $18.39M | 2.6% | $12.61 | +48.0% | COM | 039697107 |
| — | CIDARA THERAPEUTICS INC | 1,180,570 | $15.02M | 2.2% | $13.98 | — | COM | 171757107 |
| — | BLUEBIRD BIO INC | 167,367 | $14.32M | 2.1% | $49.44 | — | COM | 09609G100 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,196,603 | $13.64M | 2.0% | $9.01 | +48.2% | COM | 09058V103 |
| — | INTRA CELLULAR THERAPIES INC | 314,349 | $12.59M | 1.8% | $40.04 | — | COM | 46116X101 |
| — | PRONAI THERAPEUTICS INC | 604,982 | $12.41M | 1.8% | $20.52 | — | COM | 74346L101 |
| — | ALCOBRA LTD | 1,832,911 | $11.07M | 1.6% | $6.46 | — | SHS | M2239P109 |
| — | THERAPEUTICSMD INC | 1,518,460 | $8.898M | 1.3% | $3.00 | — | COM | 88338N107 |
| — | NEURODERM LTD | 425,000 | $8.785M | 1.3% | $20.67 | — | ORD SHS | M74231107 |
| NTRA | NATERA INC | 783,521 | $8.501M | 1.2% | $16.90 | 0.0% | COM | 632307104 |
| XNCR | XENCOR INC | 679,885 | $8.315M | 1.2% | $11.47 | +70.6% | COM | 98401F105 |
| SGMO | SANGAMO BIOSCIENCES INC | 1,445,430 | $8.152M | 1.2% | $9.09 | -9.3% | COM | 800677106 |
| — | TENAX THERAPEUTICS INC | 2,670,300 | $8.011M | 1.2% | $3.92 | — | COM | 88032L100 |
| — | NIVALIS THERAPEUTICS INC | 612,863 | $7.949M | 1.1% | $15.15 | — | COM | 65481J109 |
| — | ZYNERBA PHARMACEUTICALS INC | 525,000 | $7.513M | 1.1% | $14.31 | — | COM | 98986X109 |
| — | SERES THERAPEUTICS INC | 246,645 | $7.311M | 1.0% | $41.50 | — | COM | 81750R102 |
| — | AKARI THERAPEUTICS PLC | 263,921 | $6.333M | 0.9% | $24.00 | — | SPONSORED ADR | 00972G108 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 56,067 | $5.4M | 0.8% | $114.50 | 0.0% | COM | 90400D108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 63,026 | $5.065M | 0.7% | $111.10 | 0.0% | COM | 02043Q107 |
| — | BELLICUM PHARMACEUTICALS INC | 315,704 | $4.587M | 0.7% | $9.10 | — | COM | 079481107 |
| — | AGILE THERAPEUTICS INC | 630,702 | $4.251M | 0.6% | $9.27 | — | COM | 00847L100 |
| — | ARCA BIOPHARMA INC | 811,227 | $4.024M | 0.6% | $4.96 | — | COM PAR$.001 | 00211Y407 |
| — | VITAE PHARMACEUTICALS INC | 321,161 | $3.536M | 0.5% | $11.01 | — | COM | 92847N103 |
| — | EPIZYME INC | 227,092 | $2.92M | 0.4% | $12.86 | — | COM | 29428V104 |
| — | AURIS MED HLDG AG | 467,572 | $1.665M | 0.2% | $5.77 | — | COM | H03579101 |
| — | APPLIED GENETIC TECHNOL CORP | 121,100 | $1.591M | 0.2% | $13.14 | — | COM | 03820J100 |
| — | NOVAVAX INC | 162,060 | $1.146M | 0.2% | $2.24 | — | COM | 670002104 |
| — | VICAL INC | 2,084,078 | $958K | 0.1% | $1.09 | — | COM | 925602104 |
| — | BENITEC BIOPHARMA LTD | 140,548 | $864K | 0.1% | $6.15 | — | SPONS ADR NEW | 082053307 |
| — | DURECT CORP | 381,800 | $745K | 0.1% | $2.39 | — | COM | 266605104 |
| — | WAFERGEN BIO-SYSTEMS INC | 205,400 | $279K | 0.0% | $4.35 | — | COM PAR$ | 93041P308 |
| — | AMPLIPHI BIOSCIENCES CORP | 65,100 | $257K | 0.0% | $3.95 | — | COM NEW | 03211P202 |